Showing results (211-220 of 325) with videos related to

Sort By:
Pageof 33
Archivos Espanoles De Urologia|July 24, 1998
[Prostate cancer in the transition zone in sympatomatic patients with no rectal signs and negative peripheral zone biopsy]F Herranz Amo, J M Díez Cordero, F Verdú Tartajo, et al.
AJOG Global Reports|June 12, 2025
Temporal trends and clinical characteristics associated with pregnancy-related acute kidney injury in England: a population-based cohort studyLisiane F Leal, Kristian B Filion, Robert W Platt, et al.
Actas Urologicas Espanolas|February 12, 2000
[Incidental prostatic cancer]F Herranz Amo, J M Díez Cordero, F Verdú Tartajo, et al.
Actas Urologicas Espanolas|July 31, 1999
[The diagnostic effectiveness of repeat echo-guided transrectal biopsy as a function of the clinical and anatomicopathological findings]F Herranz Amo, J M Díez Cordero, F Verdú Tartajo, et al.
Actas Urologicas Espanolas|April 4, 2000
[Usefulness of free PSA/total PSA ratio in the diagnosis of prostatic cancer in symptomatic patients with PSA levels ranging from 2.5 to 20 ng/ml]F Herranz Amo, F Verdú Tartajo, J M Díez Cordero, et al.
Archivos Espanoles De Urologia|November 10, 1998
[Cystic carcinoma of the prostate. Echographic diagnosis]F Herranz Amo, J M Díez Cordero, F Verdú Tartajo, et al.
Actas Urologicas Espanolas|June 1, 1997
[Yield of transrectal ultrasonography in the diagnosis of prostatic cancer in symptomatic patients with normal rectal digital test]F Herranz Amo, F Verdu Tartajo, J M Diez Cordero, et al.
Archivos Espanoles De Urologia|February 19, 2000
[Clinical and ultrasonographic characteristics of prostatic cancer diagnosed with transrectal biopsy]F Herranz Amo, F Verdú Tartajo, J M Díez Cordero, et al.
Animal Reproduction Science|September 17, 2018
Absence of seminal plasma from sperm-rich fraction decreases boar sperm quality characteristics during the course of liquid storageD F Leal, M A Torres, G M Ravagnani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2005
Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trialB P Coudert, L Arnould, L Moreau, et al.
Pageof 33